Riggs Asset Management’s Gilead Sciences GILD Stock Holding History

Riggs Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-156	Closed	-$17.3K	–	403
2025 Q2	$17.3K	Hold	156	–	–	﹤0.01%	256
2025 Q1	$17.5K	Buy	156 +1	+0.6%	+$103	0.01%	228
2024 Q4	$14.3K	Buy	155 +150	+3,000%	+$13.5K	﹤0.01%	233
2024 Q3	$420	Buy	+5	New	+$382	﹤0.01%	563
2016 Q4	–	Sell	-172	Closed	-$14K	–	267
2016 Q3	$14K	Sell	172 -75	-30%	-$6.09K	0.01%	179
2016 Q2	$21K	Hold	247	–	–	0.01%	154
2016 Q1	$23K	Hold	247	–	–	0.02%	136
2015 Q4	$25K	Hold	247	–	–	0.01%	139
2015 Q3	$24K	Hold	247	–	–	0.01%	131
2015 Q2	$29K	Buy	247 +147	+147%	+$16.1K	0.01%	147
2015 Q1	$10K	Hold	100	–	–	﹤0.01%	213
2014 Q4	$9K	Buy	+100	New	+$10.3K	﹤0.01%	221

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Riggs Asset Management's GILD Position: Q3 2025 in Review

Riggs Asset Management sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 156 shares — an estimated $17.3K sold.

Riggs Asset Management first reported a position in GILD in Q4 2014 and held it in 12 quarters. The position peaked at $29K in Q2 2015. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

Riggs Asset Management reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
Riggs Asset Management sold 156 Gilead Sciences shares in Q3 2025, an estimated $17.3K.
Riggs Asset Management first reported a position in Gilead Sciences in Q4 2014 and held it in 12 quarters.
Riggs Asset Management's Gilead Sciences position peaked at $29K in Q2 2015.
2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.